Aktiviere Job-Benachrichtigungen per E-Mail!
A clinical-stage biotechnology company in Basel is seeking a Data Scientist specializing in mass spectrometry-based proteomics. This role involves analyzing complex proteomics datasets, developing algorithms, and creating data visualizations to support drug discovery efforts. Candidates should have a PhD or MS in a relevant field, along with experience in data analysis and programming. This full-time position supports the advancement of innovative therapeutic solutions.
We are seeking a highly skilled Data Scientist specializing in mass spectrometry-based proteomics to join our data science team. In this role, you will leverage advanced analytical techniques to extract meaningful insights from complex proteomics datasets generated by state-of-the-art mass spectrometry techniques. You\'ll play a crucial role in accelerating our molecular glue discovery platform by developing robust data science workflows that bridge high-throughput screening data with biological understanding.
Interested Candidates may forward a CV and Cover Letter in a single PDF via our on-line portal https://www.monterosatx.com/careers/
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa’s QuEEN (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to rationally design MGDs with unprecedented selectivity. Monte Rosa has developed the industry’s leading pipeline of MGDs, which spans autoimmune and inflammatory diseases, oncology, and beyond. Monte Rosa has a global license agreement with Novartis to advance VAV1-directed molecular glue degraders and a strategic collaboration with Roche to discover and develop MGDs against targets in cancer and neurological diseases previously considered impossible to drug. For more information, visit www.monterosatx.com.
Referrals increase your chances of interviewing at Monte Rosa Therapeutics by 2x
We’re sharing knowledge and opportunities across our community. For more information, visit www.monterosatx.com.